REPORT ID 4489

United States Gastric Motility Disorder Drug Market Report 2019

Publish Date
2019
Pages
98
Format
Electronic (PDF)

In this report, the United States Gastric Motility Disorder Drug market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Gastric Motility Disorder Drug in these regions, from   2019 to 2025 (forecast).

United States Gastric Motility Disorder Drug market competition by top manufacturers/players, with Gastric Motility Disorder Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Theravance, Inc.
    Helsinn Healthcare S.A.
    Concert Pharmaceuticals, Inc.
    Targacept, Inc.
    ChironWells GmbH
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Velusetrag
    Ipamorelin
    TD-8954
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Home Use

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Gastric Motility Disorder Drug Market  Report 2019
1 Gastric Motility Disorder Drug Overview
    1.1 Product Overview and Scope of Gastric Motility Disorder Drug
    1.2 Classification of Gastric Motility Disorder Drug by Product Category
        1.2.1 United States Gastric Motility Disorder Drug Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Gastric Motility Disorder Drug Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 Velusetrag
        1.2.4 Ipamorelin
        1.2.5 TD-8954
        1.2.6 Others
    1.3 United States Gastric Motility Disorder Drug Market by Application/End Users
        1.3.1 United States Gastric Motility Disorder Drug Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Use
    1.4 United States Gastric Motility Disorder Drug Market by Region
        1.4.1 United States Gastric Motility Disorder Drug Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Gastric Motility Disorder Drug Status and Prospect ( 2014-2024)
        1.4.3 Southwest Gastric Motility Disorder Drug Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Gastric Motility Disorder Drug Status and Prospect ( 2014-2024)
        1.4.5 New England Gastric Motility Disorder Drug Status and Prospect ( 2014-2024)
        1.4.6 The South Gastric Motility Disorder Drug Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Gastric Motility Disorder Drug Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Gastric Motility Disorder Drug ( 2014-2024)
        1.5.1 United States Gastric Motility Disorder Drug Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Gastric Motility Disorder Drug Revenue and Growth Rate ( 2014-2024)

2 United States Gastric Motility Disorder Drug Market Competition by Players/Suppliers
    2.1 United States Gastric Motility Disorder Drug Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Gastric Motility Disorder Drug Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Gastric Motility Disorder Drug Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Gastric Motility Disorder Drug Market Competitive Situation and Trends
        2.4.1 United States Gastric Motility Disorder Drug Market Concentration Rate
        2.4.2 United States Gastric Motility Disorder Drug Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Gastric Motility Disorder Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Gastric Motility Disorder Drug Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Gastric Motility Disorder Drug Sales and Market Share by Region ( 2014-2019)
    3.2 United States Gastric Motility Disorder Drug Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Gastric Motility Disorder Drug Price by Region ( 2014-2019)

4 United States Gastric Motility Disorder Drug Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Gastric Motility Disorder Drug Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Gastric Motility Disorder Drug Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Gastric Motility Disorder Drug Price by Type ( 2014-2019)
    4.4 United States Gastric Motility Disorder Drug Sales Growth Rate by Type ( 2014-2019)

5 United States Gastric Motility Disorder Drug Sales (Volume) by Application ( 2014-2019)
    5.1 United States Gastric Motility Disorder Drug Sales and Market Share by Application ( 2014-2019)
    5.2 United States Gastric Motility Disorder Drug Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Gastric Motility Disorder Drug Players/Suppliers Profiles and Sales Data
    6.1 Theravance, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Gastric Motility Disorder Drug Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Helsinn Healthcare S.A.
        6.2.2 Gastric Motility Disorder Drug Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Concert Pharmaceuticals, Inc.
        6.3.2 Gastric Motility Disorder Drug Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Targacept, Inc.
        6.4.2 Gastric Motility Disorder Drug Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 ChironWells GmbH
        6.5.2 Gastric Motility Disorder Drug Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    ...

7 Gastric Motility Disorder Drug Manufacturing Cost Analysis
    7.1 Gastric Motility Disorder Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Gastric Motility Disorder Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Gastric Motility Disorder Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Gastric Motility Disorder Drug Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Gastric Motility Disorder Drug Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Gastric Motility Disorder Drug Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Gastric Motility Disorder Drug Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Gastric Motility Disorder Drug Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Gastric Motility Disorder Drug Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer